SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-22-000061
Filing Date
2022-08-04
Accepted
2022-08-04 07:11:09
Documents
68
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnce-20220630.htm   iXBRL 10-Q 1719416
2 EX-3.1 exhibit31restatedcertifica.htm EX-3.1 171126
3 EX-31.1 q22022exhibit311.htm EX-31.1 10678
4 EX-31.2 q22022exhibit312.htm EX-31.2 10644
5 EX-32.1 q22022exhibit321.htm EX-32.1 6151
6 EX-32.2 q22022exhibit322.htm EX-32.2 6076
  Complete submission text file 0001367920-22-000061.txt   7549582

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20220630.xsd EX-101.SCH 44587
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20220630_cal.xml EX-101.CAL 58091
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20220630_def.xml EX-101.DEF 233140
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20220630_lab.xml EX-101.LAB 591995
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20220630_pre.xml EX-101.PRE 389835
62 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20220630_htm.xml XML 1163575
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 221134642
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences